Literature DB >> 17884022

A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex.

Eric J Downer1, Aoife Gowran, Veronica A Campbell.   

Abstract

The maternal use of cannabis during pregnancy results in a number of cognitive deficits in the offspring that persist into adulthood. The endocannabinoid system has a role to play in neurodevelopmental processes such as neurogenesis, migration and synaptogenesis. However, exposure to phytocannabinoids, such as Delta(9)-tetrahydrocannabinol, during gestation may interfere with these events to cause abnormal patterns of neuronal wiring and subsequent cognitive impairments. Aberrant cell death evoked by Delta(9)-tetrahydrocannabinol may also contribute to cognitive deficits and in cultured neurones Delta(9)-tetrahydrocannabinol induces apoptosis via the CB(1) cannabinoid receptor. In this study we report that Delta(9)-tetrahydrocannabinol (5-50 microM) activates the stress-activated protein kinase, c-jun N-terminal kinase, and the pro-apoptotic protease, caspase-3, in in vitro cerebral cortical slices obtained from the neonatal rat brain. The proclivity of Delta(9)-tetrahydrocannabinol to impact on these pro-apoptotic signalling molecules was not observed in in vitro cortical slices obtained from the adult rat brain. In vivo, subcutaneous administration of Delta(9)-tetrahydrocannabinol (1-30 mg/kg) activated c-jun N-terminal kinase, caspase-3 and cathepsin-D, and induced DNA fragmentation in the cerebral cortex of neonatal rats. In contrast, in vivo administration of Delta(9)-tetrahydrocannabinol to adult rats was not associated with the apoptotic pathway in the cerebral cortex. The data provide evidence which supports the hypothesis that the neonatal rat brain is more vulnerable to the neurotoxic influence of Delta(9)-tetrahydrocannabinol, suggesting that the cognitive deficits that are observed in humans exposed to marijuana during gestation may be due, in part, to abnormal engagement of the apoptotic cascade during brain development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884022     DOI: 10.1016/j.brainres.2007.07.076

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.

Authors:  M Alvaro-Bartolomé; S Esteban; M S García-Gutiérrez; J Manzanares; O Valverde; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Dual neuroprotective and neurotoxic effects of cannabinoid drugs in vitro.

Authors:  Anastasia Bologov; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Cell Mol Neurobiol       Date:  2010-11-04       Impact factor: 5.046

Review 3.  The dual neuroprotective-neurotoxic profile of cannabinoid drugs.

Authors:  Yosef Sarne; Fadi Asaf; Miriam Fishbein; Mikhal Gafni; Ora Keren
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Prenatal exposure to tobacco and cannabis: Effects on autonomic and emotion regulation.

Authors:  Rina D Eiden; Pamela Schuetze; Shannon Shisler; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-05-01       Impact factor: 3.763

5.  CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling.

Authors:  Stefania Trazzi; Martin Steger; Valentina Maria Mitrugno; Renata Bartesaghi; Elisabetta Ciani
Journal:  J Biol Chem       Date:  2010-01-18       Impact factor: 5.157

6.  Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction.

Authors:  Posung Jeon; Sungjun Yang; Hojoong Jeong; Hyun Kim
Journal:  Anat Cell Biol       Date:  2011-06-30

7.  Prenatal substance exposure and maternal hostility from pregnancy to toddlerhood: Associations with temperament profiles at 16 months of age.

Authors:  Brendan D Ostlund; Koraly E Pérez-Edgar; Shannon Shisler; Sarah Terrell; Stephanie Godleski; Pamela Schuetze; Rina D Eiden
Journal:  Dev Psychopathol       Date:  2021-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.